| # | Country | Total Patents | |
|---|---|---|---|
| #1 | Japan | 3 | |
| #2 | China | 2 | |
| #3 | Republic of Korea | 2 | |
| #4 | WIPO (World Intellectual Property Organization) | 2 | |
| #5 | Australia | 1 | |
| #6 | Canada | 1 | |
| #7 | EPO (European Patent Office) | 1 | |
| #8 | Israel | 1 | |
| #9 | Singapore | 1 | |
| #10 | United States | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Organic fine chemistry | |
| #3 | Audio-visual technology | |
| #4 | Telecommunications | |
| #5 | Basic materials chemistry | |
| #6 | Machines |
| # | Name | Total Patents |
|---|---|---|
| #1 | Balandrin Manuel F | 13 |
| #2 | Pesyan Amir | 11 |
| #3 | Amir Pesyan | 3 |
| #4 | Balandrin Manuel M | 1 |
| Publication | Filing date | Title |
|---|---|---|
| WO2017066103A1 | Novel compounds advantageous in the treatment of central nervous system diseases and disorders | |
| US2016137592A1 | Compounds advantageous in the treatment of central nervous system diseases and disorders | |
| CA2718723A1 | Novel compounds advantageous in the treatment of central nervous system diseases and disorders | |
| SG188916A1 | Novel compounds advantageous in the treatment of central nervous system diseases and disorders |